Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

NCT06399003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles-Mumps-Rubella

Interventions

BIOLOGICAL: SIBP MMR Vaccine
BIOLOGICAL: GSK MMR Vaccine (PRIORIX)
BIOLOGICAL: Yellow Fever Vaccine (Stamaril)

Sponsor

Shanghai Institute Of Biological Products

Collaborators

[object Object]